Phased implementation of screening for cryptococcal disease in South Africa
| dc.contributor.author | Govender, N.P. (Nelesh) | |
| dc.contributor.author | Chetty, V. | |
| dc.contributor.author | Roy, M. | |
| dc.contributor.author | Chiller, T. | |
| dc.contributor.author | Oladoyinbo, S. | |
| dc.contributor.author | Maotoe, T. | |
| dc.contributor.author | Stevens, W.S. | |
| dc.contributor.author | Pinini, Z. | |
| dc.contributor.author | Spencer, D. | |
| dc.contributor.author | Venter, Willem Daniel Francois | |
| dc.contributor.author | Jassat, Waasila | |
| dc.contributor.author | Cameron, David A. | |
| dc.contributor.author | Meintjes, Graeme | |
| dc.contributor.author | Mbengashe, T. | |
| dc.contributor.author | Pillay, Yogan | |
| dc.date.accessioned | 2013-05-30T06:28:42Z | |
| dc.date.available | 2013-05-30T06:28:42Z | |
| dc.date.issued | 2012-12 | |
| dc.description.abstract | Cryptococcus neoformans is the most common cause of laboratoryconfirmed meningitis in South Africa.1 Despite the increased coverage of antiretroviral treatment (ART), the country’s incidence of cryptococcal meningitis remains high, and in routine care settings, the disease has a case-fatality ratio of >50% at 12 weeks post-diagnosis.2-4 Screening and pre-emptive antifungal treatment is desirable to prevent the development of cryptococcal meningitis and associated deaths. | en_US |
| dc.description.librarian | am2013 | en_US |
| dc.description.uri | www.samj.org.za | en_US |
| dc.identifier.citation | Govender, NP, Chetty, V, Roy, M, Chiller, T, Oladoyinbo, S, Maotoe, T, Stevens, WS, Pinini, Z, Spencer, D, Venter, WDF, Jassat, W, Cameron, D, Meintjes, G, Mbengashe, T & Pillay, Y 2012, 'Phased implementation of screening for cryptococcal disease in South Africa', South African Medical Journal, vol. 102, no. 12, pp. 914-917. | en_US |
| dc.identifier.issn | 0256-9574 (print) | |
| dc.identifier.issn | 2078-5135 (online) | |
| dc.identifier.other | 10.7196/SAMJ.6228 | |
| dc.identifier.uri | http://hdl.handle.net/2263/21568 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | Health and Medical Publishing Group | en_US |
| dc.subject | Cryptococcal disease | en_US |
| dc.subject | Cryptococcus neoformans | en_US |
| dc.subject | Meningitis in South Africa | en_US |
| dc.title | Phased implementation of screening for cryptococcal disease in South Africa | en_US |
| dc.type | Article | en_US |